Not applicableStudy completedNCT02155192What this trial is testingAn Exploratory Genetic Study in Participants With PsoriasisWho this might be right forPsoriasis Janssen Research & Development, LLC 712
Large-scale testing (Phase 3)Study completedNCT03219437What this trial is testingA Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie 104
Post-approval studies (Phase 4)Ended earlyNCT00608777What this trial is testingEffect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)Who this might be right forPlaque Psoriasis Derm Research, PLLC 6
Testing effectiveness (Phase 2)Study completedNCT01384630What this trial is testingSafety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe PsoriasisWho this might be right forPsoriasis Janssen Research & Development, LLC 8
Testing effectiveness (Phase 2)Study completedNCT03000075What this trial is testingBI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis AbbVie 182
Large-scale testing (Phase 3)Study completedNCT07712731What this trial is testingHPP737 in Adult Patients With Plaque PsoriasisWho this might be right forPsoriasis Newsoara Biopharma Co., Ltd. 607
Testing effectiveness (Phase 2)Study completedNCT04173637What this trial is testingClinical Study of AK101 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Akeso 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06926582What this trial is testingEvaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque PsoriasisWho this might be right forPsoriasis Hansoh BioMedical R&D Company 305
Not applicableLooking for participantsNCT05644782What this trial is testingDietary Approach to Mild-to-moderate PsoriasisWho this might be right forPsoriasisGluten Sensitivity University of Palermo 82
Testing effectiveness (Phase 2)UnknownNCT06058546What this trial is testingEfficacy and Safety of Jiuweihuaban Pill for Treating Plaque PsoriasisWho this might be right forPlaque Psoriasis Tasly Pharmaceutical Group Co., Ltd 180
Large-scale testing (Phase 3)Study completedNCT01365455What this trial is testingEfficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 YearWho this might be right forModerate to Severe Plaque-type Psoriasis Novartis Pharmaceuticals 738
Large-scale testing (Phase 3)Study completedNCT06973291What this trial is testingA Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque PsoriasisWho this might be right forPlaque Psoriasis Takeda 606
Testing effectiveness (Phase 2)Study completedNCT00333411What this trial is testingDouble-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe PsoriasisWho this might be right forPsoriasis Boehringer Ingelheim 360
Testing effectiveness (Phase 2)Study completedNCT02129777What this trial is testingEfficacy and Safety of Namilumab (MT203) for Plaque PsoriasisWho this might be right forPlaque Psoriasis Takeda 122
Early research (Phase 1)Study completedNCT01484587What this trial is testingThe Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Janssen Pharmaceutical K.K. 24
Not applicableUnknownNCT06165887What this trial is testingThe Relationship Between Moderate-to-severe Psoriasis and Sleep DisturbanceWho this might be right forModerate-to-severe Psoriasis Shanghai Yueyang Integrated Medicine Hospital 156
Early research (Phase 1)Study completedNCT03058744What this trial is testingTopically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 94
Post-approval studies (Phase 4)Looking for participantsNCT03987763What this trial is testingA Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 45
Large-scale testing (Phase 3)Looking for participantsNCT07511647What this trial is testingClinical Study of QL2106 InjectionWho this might be right forPlaque Psoriasis Qilu Pharmaceutical Co., Ltd. 318
Post-approval studies (Phase 4)Study completedNCT03331835What this trial is testingA Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Vulgaris LEO Pharma 210